PARICAM

PARICAM is an innovative project provider in drug development for the pharmaceutical industry, specialized in inflammatory health care, from Berlin / Germany. The company focuses on transfer of cutting-edge research to unrecognized growing markets in public health. Our Key Focus today is an Investigational Drug Candidate (PARICAM P-3005) for Periodontitis to restore the Oral Health on Molecular Basis via ICAM-1 Regulation with RNA Antisense Technology.

Also known as: Paricam Therapeutics, Paricam Therapeutics GmbH

Primary location: Berlin Germany